Genital Neoplasms, Female
"Genital Neoplasms, Female" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumor or cancer of the female reproductive tract (GENITALIA, FEMALE).
| Descriptor ID |
D005833
|
| MeSH Number(s) |
C04.588.945.418 C13.351.937.418
|
| Concept/Terms |
Genital Neoplasms, Female- Genital Neoplasms, Female
- Neoplasms, Female Genital
- Gynecologic Neoplasms
- Neoplasms, Gynecologic
- Gynecologic Neoplasm
- Neoplasm, Gynecologic
- Female Genital Neoplasms
- Female Genital Neoplasm
- Genital Neoplasm, Female
- Neoplasm, Female Genital
|
Below are MeSH descriptors whose meaning is more general than "Genital Neoplasms, Female".
Below are MeSH descriptors whose meaning is more specific than "Genital Neoplasms, Female".
This graph shows the total number of publications written about "Genital Neoplasms, Female" by people in this website by year, and whether "Genital Neoplasms, Female" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 1 | 2 |
| 1996 | 1 | 1 | 2 |
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 2 | 1 | 3 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 1 | 2 |
| 2006 | 2 | 1 | 3 |
| 2008 | 0 | 2 | 2 |
| 2009 | 1 | 0 | 1 |
| 2010 | 3 | 0 | 3 |
| 2011 | 4 | 2 | 6 |
| 2012 | 2 | 0 | 2 |
| 2013 | 3 | 1 | 4 |
| 2014 | 2 | 1 | 3 |
| 2015 | 2 | 1 | 3 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 1 | 2 |
| 2018 | 2 | 1 | 3 |
| 2019 | 4 | 0 | 4 |
| 2020 | 8 | 0 | 8 |
| 2021 | 3 | 0 | 3 |
| 2022 | 3 | 0 | 3 |
| 2023 | 7 | 0 | 7 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Genital Neoplasms, Female" by people in Profiles.
-
Gynecological cancer tumor Microenvironment: Unveiling cellular complexity and therapeutic potential. Biochem Pharmacol. 2024 11; 229:116498.
-
Artificial intelligence and allied subsets in early detection and preclusion of gynecological cancers. Biochim Biophys Acta Rev Cancer. 2023 11; 1878(6):189026.
-
Phase IIa Study of PLX2853 in Gynecologic Cancers With Known ARID1A Mutation and Phase Ib/IIa Study of PLX2853/Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer. JCO Precis Oncol. 2023 09; 7:e2300235.
-
The innate effects of plant secondary metabolites in preclusion of gynecologic cancers: Inflammatory response and therapeutic action. Biochim Biophys Acta Rev Cancer. 2023 07; 1878(4):188929.
-
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer. J Immunother Cancer. 2023 06; 11(6).
-
Systematic mapping review of guidelines for BRCA1/2 genetic testing globally: investigating geographic and regional disparities in health equity for women and families at risk for hereditary ovarian cancer. Int J Gynecol Cancer. 2023 02 06; 33(2):250-256.
-
Communicating the Gynecologic Brachytherapy Experience (CoGBE): Clinician perceived benefits of a graphic narrative discussion guide. Brachytherapy. 2023 May-Jun; 22(3):352-360.
-
Cytopathology in Gynecology and Gynecologic Oncology: Updates, Recent Advances, and Practical Considerations. Acta Cytol. 2023; 67(2):109-110.
-
Practical Approach to the Evaluation of Malignant Peritoneal Fluids in the Setting of Gynecologic Neoplasms. Acta Cytol. 2023; 67(2):143-175.
-
The complex and often confusing history, histology and histogenesis of mesonephric, STK11 adnexal tumour and mesonephric-like neoplasms of the upper female genital tract (including broad ligament). Histopathology. 2022 Sep; 81(3):280-296.